Feb 17, 2026 08:00AM
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM
Jan 8, 2026 08:00AM
Dec 1, 2025 04:17PM
Nov 10, 2025 04:05PM
Aug 14, 2025 04:05PM Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Aug 7, 2025 04:31PM
Aug 7, 2025 04:30PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM
Jun 18, 2025 04:05PM
May 19, 2025 04:07PM
May 19, 2025 04:05PM Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
May 12, 2025 08:00AM
May 9, 2025 05:00PM
May 7, 2025 08:00AM
Apr 9, 2025 07:00AM
Apr 8, 2025 04:05PM
Apr 3, 2025 06:18PM
Mar 3, 2025 08:00AM Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones
Feb 13, 2025 08:30AM
Dec 17, 2024 06:53AM
Dec 16, 2024 07:31AM
Dec 16, 2024 07:30AM
Dec 5, 2024 08:00AM
Nov 14, 2024 08:00AM
Oct 21, 2024 08:00PM Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
Oct 15, 2024 08:02AM
Oct 15, 2024 08:00AM
Sep 9, 2024 08:00AM
Aug 13, 2024 09:28AM
Aug 12, 2024 08:00AM
Aug 5, 2024 08:00AM
Jul 11, 2024 06:09PM Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting
Jun 25, 2024 05:00PM
Jun 25, 2024 05:00PM
Jun 18, 2024 08:00AM
Jun 4, 2024 07:00AM
Jun 4, 2024 07:00AM
May 7, 2024 12:30PM
Apr 16, 2024 09:00AM Turnstone Biologics Appoints William Waddill to its Board of Directors
Mar 26, 2024 04:05PM
Feb 21, 2024 08:00AM
Feb 21, 2024 08:00AM
Dec 20, 2023 05:12PM
Dec 20, 2023 05:10PM
Nov 13, 2023 06:31AM
Nov 13, 2023 06:30AM Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results
Nov 13, 2023 06:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All